Head-to-head · Cost-Efficiency Index
Breeze Meds vs eMI Aesthetics
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Breeze Meds
People who want to independently verify the clinicians and pharmacy behind their GLP-1 — and who'll pay a mid-market price for that paper trail plus FSA/HSA eligibility.
Visit Breeze MedseMI Aesthetics
Shoppers wanting compounded sema or tirz in all 50 states with an ai progress simulator.
Visit eMI AestheticsThe verdict
Breeze Meds takes it, leading the Cost-Efficiency Index 86 to 70. The most transparent operator in our partner tier — all-50 compounded GLP-1 with NPI-verifiable named physicians, named pharmacies and LegitScript backing, so you can actually audit who's behind the script. eMI Aesthetics still earns a C — Shoppers wanting compounded sema or tirz in all 50 states with an ai progress simulator.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Breeze Meds.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Breeze Meds | eMI Aesthetics |
|---|---|---|
| Cost-Efficiency Index | 86/100 | 70/100 |
| Semaglutide / mo | $199/mo | $179/mo (all doses, compounded) |
| Tirzepatide / mo | $399/mo | Not disclosed |
| Semaglutide / yr (modeled) | $2,388 | $2,148 |
| Tirzepatide / yr (modeled) | $4,788 | — |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Yes |
| Rank on the board | #5 | #97 |
Breeze Meds
86/100Where the value is
- Best transparency of this partner batch — NPI-verifiable named physicians (Lion MD group), named dispensing pharmacies, and LegitScript certification
- All 50 states, with injectable semaglutide from $199/mo plus oral semaglutide (~$299) and oral tirzepatide (~$399) for the needle-averse
- FSA/HSA eligible, which trims the effective monthly cost
The tradeoffs
- Mid-to-higher per-month pricing — tirzepatide and the oral routes carry a premium over the cheapest all-50 rivals
- Compounded only — not FDA-approved brand-name medication
eMI Aesthetics
70/100Where the value is
- Available to eligible patients in all 50 states
- Offers both semaglutide and tirzepatide, plus an oral semaglutide option
- Intake and provider visits run through OpenLoop Health, an established telehealth network
The tradeoffs
- Full per-drug pricing is not shown before intake; only an 'as low as 179/month' starting rate is published
- No fill pharmacy or named medical director is publicly listed
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.